MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from offering,
net-Underwritten Offering
$432,400K
Proceeds from offering,
net-At The Market...
$58,630K
something is missing
$34,489K
Proceeds from shares
issued under equity...
$4,055K
Net cash provided by
financing activities
$529,549K
Canceled cashflow
$25K
Net increase
(decrease) in cash and cash...
$134,462K
Canceled cashflow
$395,087K
Payments of offering
costs associated with...
$25K
Maturities of investments
$101,482K
Payment of transaction
costs and working...
-$697K
Non-cash interest
expense on liabilities...
$7,942K
Stock-based compensation
$3,355K
Accrued expenses
$2,326K
Loss from equity
method investment
-$1,750K
Other assets
-$949K
Depreciation and
amortization expense
$151K
Net cash provided by
(used in) investing...
-$350,789K
Net cash used in
operating activities
-$44,298K
Canceled cashflow
$102,179K
Canceled cashflow
$16,473K
Purchases of investments
$452,253K
Net loss
-$44,904K
Purchases of property and
equipment
$18K
Non-cash royalty revenue
related to the sales of...
$10,861K
Operating leases, net
$2,409K
Amortization of premiums
(discounts), net
-$1,663K
Accounts payable
-$934K
Loss before equity
method investment
-$43,154K
Loss from equity
method investment
-$1,750K
Loss before
provision for income taxes...
-$43,090K
Provision for income taxes
$64K
Revenue
$10,861K
Interest income
$4,242K
Loss from operations
-$39,054K
Total non-operating
income (expense), net
-$4,036K
Canceled cashflow
$10,861K
Canceled cashflow
$4,242K
Total operating costs
and expenses
$49,915K
Non-cash interest
expense on liabilities...
$7,942K
Other income
(expense), net
-$336K
Discovery Research And
Other Programs
-$104K
Clinical development,
contract manufacturing...
$21,430K
Employee costs
$13,678K
Other operating costs
$7,702K
Other segment
expenses
$4,272K
Facilities costs
$2,833K
Canceled cashflow
$104K
Rezpegaldesleukin
$20,736K
TNFR2Program
$798K
Back
Back
Cash Flow
NEKTAR THERAPEUTICS (NKTR)
NEKTAR THERAPEUTICS (NKTR)
source: myfinsight.com